Global Health IPO – Review, Bid, Size, Allotment, Subscription, GMP & RHP
Last Updated Date: Nov 17, 2022Global Health Limited, a leading name as a multi-speciality tertiary care provider, is opening its IPO on 3rd November.
Global Health IPO consists of Fresh Issue to raise Rs. 500 crores and an Offer for Sale for 50,761,000 Equity Shares. The company is raising funds for investing in two of its subsidiaries and for selling equity shares by the selling shareholders.
In this Global Health IPO Review, we will discuss this IPO, its objects, important dates, subscription, allotment, and other important details related to the company and the IPO.
| Face Value | Rs.2 |
| Price Band | 319 to 336 per share |
| Listing At | BSE, NSE |
| Min. Order Quantity | 44 Shares |
| Listing Date | Nov 16, 2022 |
| Offer for Sale | Rs. 1,705.57 Crore |
| Fresh Issue | Rs. 500.00 Crore |
| IPO Size | Rs. 2,205.57 Crore |
| Tick Size | 1 |
Global Health IPO Overview
Global Health IPO will soon hit the streets of the stock market. Through the IPO, the multi-speciality healthcare company is offering shares to the public in the form of fresh issues and share sales.
In the IPO, Investor Selling Shareholder Anant Investments will be offloading up to 50,661,000 Equity Shares, and Individual Selling Shareholder Sunil Sachdeva (jointly held with Suman Sachdeva) will sell up to 100,000 Equity Shares.
The IPO will be open from 3rd November to 7th November for subscriptions from prospective shareholders.
Global Health IPO Important Dates
| Events | Date |
| IPO Opening Date | Nov 3, 2022 |
| IPO Closing Date | Nov 7, 2022 |
| Basis of Allotment Finalization | Nov 11, 2022 |
| Refunds Initiation | Nov 14, 2022 |
| Credit of Shares to Demat Account | Nov 15, 2022 |
| Share Listing Date | Nov 16, 2022 |
You will get all the details about the Global health IPO dates from the table given above. The table contains details on the IPO opening date, IPO closing date, basis of allotment, credit of shares to account, refund initiation, and listing date.
Investors can bid in this IPO from 3rd November; the bidders are required to place their bids online.
Global Health IPO Price, Size, Share Offerings
| Face Value | Rs.2 |
| Price Band | Not Disclosed |
| Offer for Sale | Rs. 1,705.57 Crore |
| Fresh Issue | Rs. 500.00 Crore |
| IPO Size | Rs. 2,205.57 Crore |
Global Health IPO Size will be declared after the IPO subscription has concluded. The company is offering equity shares through Fresh Share Issue and Offer for Sale, and the shares will be listed on BSE and NSE.
The face value of the equity shares is Rs. 2 each, and the Global Health IPO Price will be determined through the Book Building Process.
Global Health IPO Grey Market Premium
| Date | GMP (Rs.) | Kostak Rate (Rs.) | Subject to Sauda (Rs.) |
| 15 Nov 2022 | Rs. 20 | Rs. 300 | Rs. 700 |
| 14 Nov 2022 | Rs. 20 | Rs. 300 | Rs. 700 |
| 12 Nov 2022 | Rs. 20 | Rs. 300 | Rs. 700 |
| 11 Nov 2022 | Rs. 20 | Rs. 300 | Rs. 700 |
| 10 Nov 2022 | Rs. 20 | Rs. 300 | Rs. 700 |
| 09 Nov 2022 | Rs. 20 | Rs. 300 | Rs. 700 |
| 08 Nov 2022 | Rs. 15 | Rs. 300 | Rs. 700 |
| 07 Nov 2022 | Rs. 15 | Rs. 300 | Rs. 700 |
| 06 Nov 2022 | Rs. 15 | Rs. 300 | Rs. 700 |
| 05 Nov 2022 | Rs. 15 | Rs. 300 | Rs. 700 |
| 04 Nov 2022 | Rs. 15 | Rs. 300 | Rs. 700 |
| 03 Nov 2022 | Rs. 15 | NA | NA |
Global Health IPO GMP can be checked from the table as you can see that the premium price changes every day are given in the sections. You can stay aware of the ongoing price levels from this table and bid in the IPO accordingly.
The price band of Global Health IPO is set at Rs. 319 to Rs. 336, and with the company’s popularity in the market, the GMP is expected to be on the higher end.
GMP plays a crucial role in the IPO market and helps traders in placing bids at suitable rates.
Global Health IPO Subscription Status
| Day / Date | QIB | NII | RII | Total Subscription |
| 1st Day – 3rd Nov | 0.54x | 0.18x | 0.12x | 0.26x |
| 2nd Day – 4th Nov | 0.56x | 0.96x | 0.25x | 0.49x |
| 3rd Day – 7th Nov | 28.64x | 4.02x | 0.88x | 9.58x |
| Shares Offered or Net Issue | 13,524,905 | 9,965,248 | 23,252,244 | 46,742,397 |
The Global Health IPO Subscription will start on 3rd November and will conclude on 7th November. Bidders will place their bids online, and once all the bids have been received, the company will move ahead with the allotment of shares to the successful bidders.
In the IPO, 50% of the offer will be reserved for the Qualified Institutional Buyers (QIBs), 15% of the shares will be available for allocation to the Non-Institutional Bidders, and the 35% portion of the offer will be reserved for allocation to the Retail Individual Bidders.
Global Health IPO Allotment Status
The Global Health IPO Allotment finalization will take place on 11th November. The face value of the equity shares is Rs. 2 each, and the price will be determined after the IPO subscription.
If you are also interested in getting an allotment of these shares, you can bid online through the Application Supported by Blocked Amount process or by using your UPI ID. These two alternatives to apply in the IPO are available for all the bidders except Anchor Investors.
Global Health IPO Live Performance
Check out the Global Health IPO Performance and make your entrance into the stock market with these stocks. The company’s stocks will be listed on 16th November, and then they will be traded online in the secondary market.
Subscribe to Global Health IPO – Open Free Demat Account Now!
Latest Global Health IPO News
Global health IPO will open on 3rd November, so the investors and traders who were eyeing this IPO should get ready. This buzzing IPO will remain open till 7th November for the subscription. Further, the offered shares in the IPO will be listed on the mainboard exchanges on 16th November 2022.
Global Health – Company Review
Incorporate as a Private Limited Company, Global Health was incorporated in 2004 and today is nearly standing on completing two decades of its operations.
Global Health Limited, or GHL, is a world-known multi-speciality tertiary care provider and offers its services in a variety of dimensions. They are operating in the North and East regions of India and have four hospitals located in Lucknow, Indore, Gurugram, and Ranchi.
Gurugram hospital of Global Health was ranked as the Best Hospital in India for three consecutive years, i.e., 2020, 2021, and 2022. Further, it was featured in the top 200 Global hospitals in 2021 and in the top 250 in 2022 by Newsweek.
Products or Services
Global Health Limited operates under its brand “Medanta.” It established “The Medanta Institutional Tissue Repository” in 2017 in order to promote biomarker and other tissue-based research.
Under one roof, Global Health is solving and aiding in numerous medical and health conditions and helping individuals live their life to the fullest. The company’s speciality includes neurosciences, cardiology, cardiac science, orthopaedics, oncology, digestive and hepatobiliary sciences, kidney and urology, and liver transplant.
In terms of capacity, the operational hospital of Global Health has 2,467 installed beds. In June 2022, the company was providing healthcare services in over 30 medical specialities.
Promoters and Holding
The Promoter of Global Health Limited is Dr. Naresh Trehan.
The management of the company comprises the following:
- Naresh Trehan, in the position of Chairman and Managing Director
- Sunil Sachdeva, in the position of Non-Executive Director
- Ravi Kant Jaipuria, in the position of Non-Executive Nominee Director (nominee of RJ Corp)
- Venkatesh Ratnasami, in the position of Non-Executive Nominee Director (nominee of Dunearn)
- Praveen Mahajan, in the position of Non-Executive Independent Director
- Vikram Singh Mehta, in the position of Non-Executive Independent Director
- Hari Shanker Bhartia, in the position of Non-Executive Independent Director
- Rajan Bharti Mittal, in the position of Non-Executive Independent Director
- Ravi Gupta, in the position of Non-Executive Independent Director
- Pankaj Prakash Sahni, in the position of Group Chief Executive Officer
- Sanjeev Kumar, in the position of Group Chief Financial Officer
- Rajiv Sikka, in the position of Chief Information Officer
- Bhuvander Kaul, in the position of Chief Procurement Officer
- Manoj Gupta, in the position of Senior Vice President and Head – Human Resources
- Richa Singh, in the position of General Counsel
- Sumanta Ray, in the position of Chief Marketing and Growth Officer
- Rahul Ranjan, in the position of Company Secretary and Compliance officer
Is Global Health good for Investment?
Global Health Limited is a leading tertiary and quaternary care provider operating in India. For nearly two decades, Global health has been serving critical medical problems for patients with its expertise and highly experienced team of doctors. As of 2022, the company engages over 1300 doctors offering their discrete specialization.
Global Health majorly focuses on clinical research and academics. It specializes in over 30 medical aspects and offers its services through large-scale hospitals built with world-class infrastructure, up-top technology, and exclusive medical equipment.
Further, Global Health is looking for higher opportunities in its current operational capacities and erupt into new dimensions where it can offer solutions for many other health problems.
Global Health Financial Statements
| Amount (in INR & Million) | |||||
| 30-Jun-2022 | 30-Jun-2021 | 31-Mar-2022 | 31-Mar-2021 | 31-Mar-2020 | |
| Assets | 32,219.36 | 28,551.07 | 31,455.17 | 26,941.05 | 26,662.87 |
| Revenue | 6,265.44 | 4,915.79 | 22,058.17 | 14,781.58 | 15,442.67 |
| Expense | 5,395.12 | 4,333.88 | 19,252.56 | 14,456.94 | 14,803.78 |
| Profit After Tax | 587.12 | 417.58 | 1,962.02 | 288.05 | 363.27 |
Along with the operational diversification and capabilities, the financial standings of Global Health Limited are also in good shape.
The company posted a total revenue of Rs. 22,058.17 million against a profit of Rs. 1,962.02 million for the financial year 2021-22. The profit has heightened by a significant level this year as compared to the previous financial periods.
For the first quarter of 2022, the company earned a revenue of Rs. 6,265.44 million, and for the same period, its profits stood at Rs. 587.12 million, respectively.
For further details about the assets, revenue, and profit after tax for previous years, you can refer to the table given above.
The EPS level of Global Health has been the highest in March 2022 in recent years. The Earnings per Share was Rs. 7.78. And for the latest period, as of 30th June 2022, EPS was Rs. 2.32.
| Earnings per Equity Share (in Million) | |||||
| 30-Jun-2022 | 30-Jun-2021 | 31-Mar-2022 | 31-Mar-2021 | 31-Mar-2020 | |
| Basic | 2.32 | 1.67 | 7.78 | 1.15 | 1.45 |
| Diluted | 2.31 | 1.67 | 7.77 | 1.14 | 1.44 |
Global Health IPO Review
The Global Health IPO is a combination of a Fresh issue of Equity Shares and an Offer for Sale by the Investor selling shareholders. The company will be raising about Rs. 500 crores through the fresh issue, whereas existing shareholders will be selling upto 5,07,61,000 Equity Shares.
The company is raising funds through the IPO for the purpose of investing in two of its subsidiaries, namely GHPPL and MHPL, and to execute the sale of equity shares by the shareholders.
The company will be receiving the proceeds from the fresh issue, and the selling shareholders will be entitled to receive the proceeds from the sale of their shares.
Also, the company, in a nutshell, is a highly prosperous and returns-yielding investment prospect. The operations are diverse, and it operates as a leading brand in the industry. Also, the importance of the medical industry is not unknown to any individual.
Global Health IPO Details
Here are few more details you need to know before investing in Global Health IPO –
Global Health IPO Issue Object
- Investment in two of our Subsidiaries, GHPPL and MHPL, in the form of debt or equity for repayment/prepayment of borrowings, in full or part, of such Subsidiaries
- General corporate purposes
Global Health IPO – Basis of Offer Price
The issue price is determined by the company in consultation with the Lead manager on the basis of the following qualitative and quantitative factors.
Qualitative factors are:
- Tertiary and quaternary care provider in India, recognised for clinical expertise in particular in dealing with complicated cases;
- Focus on clinical research and academics;
- Doctor-led hospitals driven by skilled and experienced doctors in the healthcare space;
- Large-scale hospitals with sophisticated infrastructure, medical equipment and technology;
- Track record of operational and financial performance;
- Focus on under-served areas with dense populations and presence in top or capital cities of large states (NCR, Lucknow and Patna);
- Growth opportunities in existing facilities and diversification into new services, including digital health; and
- Experienced senior management team with institutional shareholder support.
Quantitative factors are:
| Basic EPS | Diluted EPS | RONW (%) | NAV (Rs.) | |
| 31-Mar-22 | 7.78 | 7.77 | 12.14 | 63.82 |
| 31-Mar-21 | 1.15 | 1.14 | 2.08 | 55.76 |
| Mar-20 | 1.45 | 1.44 | 2.69 | 54.70 |
Global Health IPO Lead Managers
Here are the list of Lead managers –
- Kotak Mahindra Capital Company Limited
- Credit Suisse Securities (India) Private Limited
- Jefferies India Private Limited
- JM Financial Limited
Global Health IPO Registrar to offer
Check out the details of the registrar here –
KFin Technologies Limited (formerly known as KFin Technologies Private Limited)
Selenium, Tower-B
Plot 31 and 32, Financial District
Nanakramguda, Serilingampally
Hyderabad, Rangareddi 500 032
Telangana, India
Tel: +91 40 6716 2222
E-mail: globalhealth.ipo@kfintech.com
Investor grievance e-mail: einward.ris@kfintech.com
Website: www.kfintech.com
Contact Person: M Murali Krishna
SEBI Registration No.: INR000000221
Global Health IPO – Other Details
- Statutory Auditor – Walker Chandiok & Co LLP, Chartered Accountants
- Legal Counsel to the Company – J. Sagar Associate
- Bankers to the Company – Yes Bank Limited, HDFC Bank Limited and ICICI Bank Limited
Global Health IPO Verdict by Stock Brokers
Accounting for the reputation of Global Health, most of the reviewing websites and words of experts have given the green light to the Global Health IPO.
The IPO is set to open on 3rd November 2022 to invite bids from the public and will close on 7th November.
Global Health IPO – Conclusion
Global Health Limited is a private multi-speciality healthcare provider operating dominantly in India’s North and east regions. Their specialty includes cardiology and cardiac science, liver transplant, and other essential and critical areas.
The Global Health IPO is going to open on 3rd November and comprises shares to be offered through the fresh issue as well as a share sale by the existing shareholders.
The company is continually expanding in shape and operations; it has four hospitals located in different areas and is looking for newer expansion horizons. Investment in this entity will be a suitable move for investors.
To Subscribe to Global Health IPO – Open Demat Account Now!
Global Health IPO Review FAQs
Check out the FAQs on Global Health IPO –
What is the Issue Size of Global Health IPO?
The Company is making an initial public offer of 50,761,000 equity shares. They vividly portray the aspects of the issue in this article.
You can check the stats on the fresh issue, Offer for sale, and net issue.
What is the Price band of Global Health IPO?
The price band for this particular IPO ranges between Rs.319 to 336. As far as the face value of the share is of concern, it is Rs.2 per share.
What is the Vaibhav Jewellers IPO Open Date?
The opening and closing dates for this IPO have been updated. The IPO is set to open on Nov 3, 2022, while the closing date is set at Nov 7, 2022.
What is the Global Health IPO Allotment Date?
They also have the news regarding the respective allotment dates of this IPO. Basis of Allotment finalization is on Nov 11, 2022, refund initiation is on Nov 14, 2022, credit of shares is on Nov 15, 2022, and share listing date is on Nov 16, 2022.
What is the Vaibhav Jewellers IPO Listing Date?
Shares of this company shall be listed in the exchanges Nov 16, 2022. The date, when the listing would be done, is stagnant on Nov 16, 2022.
Who is the Registrar of Global Health IPO?
One of the reputed registrars is managing the issue of this IPO, i.e. KFin Technologies Private Limited. Their website will help you regarding the further information you are on the lookout for.
Who is the Promoter of Vaibhav Jewellers IPO?
Here are the promoters of this IPO – DR. NARESH TREHAN. You can refer to the RHP for further information on the promoter. You will find the link to RHP in the article.
What is the GMP of Global Health IPO?
They have obtained the GMP of this IPO and it is Rs. Rs. 20 Further insights of Kostak rate and subject to sauda or SS are as well included in this report.
Is Vaibhav Jewellers IPO good for Investment?
They have further provided the financial status of the company in this article, from the past few years.
You can refer to the same, and also check the line of operations they are into and then decide to invest in the IPO.
What is the PAT of Global Health Company?
They have the information of company financials, and according to that, they have the figures from the last few years to provide. PAT for the financial year 2022 in Million is 1,962.02, 2021 is 288.05, 2020 is 363.27.
Featured Topics